title: Hairy cell leukemia.
abstract: Hairy cell leukemia is a rare B-cell neoplasm. When treated with either pentostatin or cladribine, complete and durable remissions can be secured and life expectancy for most patients is normal. A small minority of patients require alternative treatment with monoclonal antibodies or immunotoxins. Patients who attain a complete response to first-line treatment have the best prognosis.
authors.affiliation: claire.dearden@rmh.nhs.uk
authors.forename: Claire
authors.initials: C
authors.lastname: Dearden
authors.forename: Monica
authors.initials: M
authors.lastname: Else
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis
chemical_list: D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents